JP2010512404A5 - - Google Patents

Download PDF

Info

Publication number
JP2010512404A5
JP2010512404A5 JP2009541370A JP2009541370A JP2010512404A5 JP 2010512404 A5 JP2010512404 A5 JP 2010512404A5 JP 2009541370 A JP2009541370 A JP 2009541370A JP 2009541370 A JP2009541370 A JP 2009541370A JP 2010512404 A5 JP2010512404 A5 JP 2010512404A5
Authority
JP
Japan
Prior art keywords
composition
connexin
wound
polynucleotide
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009541370A
Other languages
English (en)
Japanese (ja)
Other versions
JP5431949B2 (ja
JP2010512404A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/025446 external-priority patent/WO2008073479A2/en
Publication of JP2010512404A publication Critical patent/JP2010512404A/ja
Publication of JP2010512404A5 publication Critical patent/JP2010512404A5/ja
Application granted granted Critical
Publication of JP5431949B2 publication Critical patent/JP5431949B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009541370A 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド Expired - Fee Related JP5431949B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87440406P 2006-12-11 2006-12-11
US60/874,404 2006-12-11
PCT/US2007/025446 WO2008073479A2 (en) 2006-12-11 2007-12-11 Anticonnexin polynucleotides as impaired wound healing compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013117401A Division JP5911454B2 (ja) 2006-12-11 2013-06-03 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Publications (3)

Publication Number Publication Date
JP2010512404A JP2010512404A (ja) 2010-04-22
JP2010512404A5 true JP2010512404A5 (enExample) 2012-01-19
JP5431949B2 JP5431949B2 (ja) 2014-03-05

Family

ID=39386432

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009541370A Expired - Fee Related JP5431949B2 (ja) 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド
JP2013117401A Expired - Fee Related JP5911454B2 (ja) 2006-12-11 2013-06-03 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド
JP2015000248A Pending JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013117401A Expired - Fee Related JP5911454B2 (ja) 2006-12-11 2013-06-03 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド
JP2015000248A Pending JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Country Status (15)

Country Link
US (5) US8063023B2 (enExample)
EP (3) EP2543377A1 (enExample)
JP (3) JP5431949B2 (enExample)
KR (1) KR101521306B1 (enExample)
CN (2) CN103520197B (enExample)
AU (1) AU2007333535B2 (enExample)
BR (1) BRPI0721094A2 (enExample)
CA (1) CA2672220A1 (enExample)
DK (1) DK2101791T3 (enExample)
ES (1) ES2527131T3 (enExample)
PL (1) PL2101791T3 (enExample)
PT (1) PT2101791E (enExample)
RU (1) RU2521329C2 (enExample)
SI (1) SI2101791T1 (enExample)
WO (1) WO2008073479A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2662088A3 (en) 2005-02-03 2014-02-19 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
JP5960944B2 (ja) 2006-11-15 2016-08-02 コーダ セラピューティクス， インコーポレイテッド 創傷治癒のための改善された方法および組成物
ES2527131T3 (es) 2006-12-11 2015-01-20 Coda Therapeutics, Inc. Polinucleótidos anticonexina como composiciones para la curación alterada de heridas
US20080249044A1 (en) * 2007-04-03 2008-10-09 Masaya Tanaka Nucleic acid external skin formulation
AU2008335718A1 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
CA2709151A1 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
EP2237795A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
WO2012076985A2 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
GB201117538D0 (en) * 2011-10-11 2011-11-23 Royal Veterinary College The Methods
CN104271142B (zh) 2012-03-01 2017-07-04 福斯特斯特林研究公司 含有α连接蛋白C‑末端(ACT)肽的局部凝胶
CN104736709A (zh) * 2012-03-27 2015-06-24 科达治疗公司 基于钙粘蛋白调节的组合物和治疗
US9156896B2 (en) 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
WO2015139047A2 (en) * 2014-03-14 2015-09-17 Coda Therapeutics Treatment of resistant lesions
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
CN108367017A (zh) * 2015-08-13 2018-08-03 索马根尼科斯公司 用于伤口愈合的短小发夹rna与微rna的组合物以及方法
US11096832B2 (en) * 2016-09-27 2021-08-24 Smith & Nephew Plc Wound closure devices with dissolvable portions
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
CN108588075A (zh) * 2018-05-03 2018-09-28 天德悦（北京）生物科技有限责任公司 人Cx43基因干扰序列、shRNA-Cx43病毒及低表达Cx43蛋白的细胞系
EP4232157A4 (en) 2020-10-22 2024-08-28 Xequel Bio, Inc. PEPTIDE FORMULATIONS AND ASSOCIATED OPHTHALMIC USES
RU2754383C1 (ru) * 2020-12-07 2021-09-01 Федеральное Государственное Бюджетное Учреждение "Национальный Медицинский Исследовательский Центр Эндокринологии" Министерства Здравоохранения Российской Федерации (Фгбу "Нмиц Эндокринологии" Минздрава России) Способ лечения неинфицированного послеоперационного раневого дефекта стопы при отсутствии признаков критической ишемии конечности у больных с нейропатической и нейроишемической формой синдрома диабетической стопы

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0539594Y2 (enExample) * 1988-08-05 1993-10-07
US5004810A (en) 1988-09-30 1991-04-02 Schering Corporation Antiviral oligomers
US5166195A (en) 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
GB9425930D0 (en) 1994-12-22 1995-02-22 Procter & Gamble Silicone compositions
WO1998024797A1 (en) 1996-12-02 1998-06-11 Dyad Pharmaceutical Corporation Antisense inhibition of human adhesion molecules
RU2147240C1 (ru) * 1998-02-16 2000-04-10 Рязанский областной клинический кожно-венерологический диспансер Препарат для лечения длительно незаживающих инфицированных язв и ран
CA2361251C (en) * 1999-01-27 2011-03-08 David L. Becker Formulations comprising antisense nucleotides to connexins
US7250397B2 (en) 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
JP2005509621A (ja) 2001-10-17 2005-04-14 ユニバーシティ オブ ウェールズ カレッジ オブ メディスン ギャップ結合ならびにｅｄｈｆ
CN1939529A (zh) * 2002-01-29 2007-04-04 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
JP5838017B2 (ja) 2003-12-03 2015-12-24 コーダ セラピューティクス， インコーポレイテッド コネキシンに対して標的化されたアンチセンス化合物およびその使用方法
DE102004027422A1 (de) 2004-06-04 2005-12-29 Boehringer Ingelheim Microparts Gmbh Vorrichtung zur Aufnahme von Blut und Abtrennung von Blutbestandteilen
HUE038099T2 (hu) 2004-12-21 2018-09-28 Musc Found For Res Dev Kompozíciók és módszerek sebgyógyulás és szöveti regeneráció elõsegítésére
EP2662088A3 (en) 2005-02-03 2014-02-19 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
JP5960944B2 (ja) 2006-11-15 2016-08-02 コーダ セラピューティクス， インコーポレイテッド 創傷治癒のための改善された方法および組成物
ES2527131T3 (es) 2006-12-11 2015-01-20 Coda Therapeutics, Inc. Polinucleótidos anticonexina como composiciones para la curación alterada de heridas
CN101765423B (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
CA2709151A1 (en) 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
AU2008335718A1 (en) 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
RU2009126594A (ru) Композиции и способы лечения плохо заживающих ран
Landén et al. Transition from inflammation to proliferation: a critical step during wound healing
JP2016506240A5 (enExample)
JP2011508605A5 (enExample)
US9290554B2 (en) Wound healing compositions and treatments
Horsburgh et al. MicroRNAs in the skin: role in development, homoeostasis and regeneration
RU2009122370A (ru) Улучшенные способы и композиции для заживления ран
US20110130710A1 (en) Treatment of abnormal or excessive scars
TW200950824A (en) Use of nucleic acids with reduced pressure therapy
JP2015514778A5 (enExample)
WO2017091700A1 (en) Use of microrna-146a and nanoceria conjugate to improve wound healing and promote tissue regeneration
RU2016119354A (ru) Мирнк и их применение в способах и композициях для ингибирования экспрессии гена orai1
Yang et al. Antioxidant-enriched autologous biogel promoted diabetic wound healing by remodeling inherent posttraumatic inflammatory patterning and restoring compromised microenvironment homeostasis
JP2011519365A5 (enExample)
WO2017190152A1 (en) Sustained release drug delivery devices
RU2015138544A (ru) Композиции и способы целенаправленного воздействия на О-связанную N-ацетилглюкозаминтрансферазу и стимулирования заживления ран
JP2016513968A5 (enExample)
CN112023031A (zh) SNase在制备促进糖尿病伤口愈合药物中的应用
CN121081718A (zh) 一种用于烧烫伤感染创面治疗的cogs水凝胶及其制备方法和应用
UA121496C2 (uk) Гідрогелева пов'язка для ран та опіків
RU2020105876A (ru) Способы и композиции для лечения явления кровотечения у больного гемофилией
KARINA et al. Growth Hormone Therapy in Human Burn Injury